Product Code: ETC10602126 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Human Papilloma Virus Associated Disorders Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, 2021 & 2031F |
3.3 India Human Papilloma Virus Associated Disorders Market - Industry Life Cycle |
3.4 India Human Papilloma Virus Associated Disorders Market - Porter's Five Forces |
3.5 India Human Papilloma Virus Associated Disorders Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 India Human Papilloma Virus Associated Disorders Market Revenues & Volume Share, By Treatment Class, 2021 & 2031F |
3.7 India Human Papilloma Virus Associated Disorders Market Revenues & Volume Share, By Delivery Form, 2021 & 2031F |
3.8 India Human Papilloma Virus Associated Disorders Market Revenues & Volume Share, By Target Population, 2021 & 2031F |
3.9 India Human Papilloma Virus Associated Disorders Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 India Human Papilloma Virus Associated Disorders Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about human papilloma virus (HPV) and associated disorders |
4.2.2 Growing focus on preventive healthcare measures |
4.2.3 Rising adoption of HPV vaccines in India |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 High cost associated with HPV vaccines and diagnostic tests |
4.3.3 Lack of proper screening programs for HPV in India |
5 India Human Papilloma Virus Associated Disorders Market Trends |
6 India Human Papilloma Virus Associated Disorders Market, By Types |
6.1 India Human Papilloma Virus Associated Disorders Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Cervical Dysplasia, 2021 - 2031F |
6.1.4 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Genital Warts, 2021 - 2031F |
6.1.5 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Oropharyngeal Cancer, 2021 - 2031F |
6.2 India Human Papilloma Virus Associated Disorders Market, By Treatment Class |
6.2.1 Overview and Analysis |
6.2.2 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.3 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Antiviral Therapy, 2021 - 2031F |
6.2.4 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Chemotherapy/Immunotherapy, 2021 - 2031F |
6.3 India Human Papilloma Virus Associated Disorders Market, By Delivery Form |
6.3.1 Overview and Analysis |
6.3.2 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Oral/Topical, 2021 - 2031F |
6.3.3 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Topical, 2021 - 2031F |
6.3.4 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 India Human Papilloma Virus Associated Disorders Market, By Target Population |
6.4.1 Overview and Analysis |
6.4.2 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Women, 2021 - 2031F |
6.4.3 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Adults, Adolescents, 2021 - 2031F |
6.4.4 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Adults, 2021 - 2031F |
6.5 India Human Papilloma Virus Associated Disorders Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.5.3 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By STD Prevention, 2021 - 2031F |
6.5.4 India Human Papilloma Virus Associated Disorders Market Revenues & Volume, By Cancer Therapy, 2021 - 2031F |
7 India Human Papilloma Virus Associated Disorders Market Import-Export Trade Statistics |
7.1 India Human Papilloma Virus Associated Disorders Market Export to Major Countries |
7.2 India Human Papilloma Virus Associated Disorders Market Imports from Major Countries |
8 India Human Papilloma Virus Associated Disorders Market Key Performance Indicators |
8.1 HPV vaccination coverage rate in India |
8.2 Number of healthcare facilities offering HPV screening and treatment |
8.3 Percentage of population receiving education on HPV and associated disorders |
8.4 HPV-related mortality rate in India |
8.5 Government funding allocated for HPV prevention and control efforts |
9 India Human Papilloma Virus Associated Disorders Market - Opportunity Assessment |
9.1 India Human Papilloma Virus Associated Disorders Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 India Human Papilloma Virus Associated Disorders Market Opportunity Assessment, By Treatment Class, 2021 & 2031F |
9.3 India Human Papilloma Virus Associated Disorders Market Opportunity Assessment, By Delivery Form, 2021 & 2031F |
9.4 India Human Papilloma Virus Associated Disorders Market Opportunity Assessment, By Target Population, 2021 & 2031F |
9.5 India Human Papilloma Virus Associated Disorders Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 India Human Papilloma Virus Associated Disorders Market - Competitive Landscape |
10.1 India Human Papilloma Virus Associated Disorders Market Revenue Share, By Companies, 2024 |
10.2 India Human Papilloma Virus Associated Disorders Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |